Zantac 150mg & 300mg Tablet
PDF Leaflet Revision Date: 30 September 2016
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of duodenal ulcers, gastric ulcers, reflux oesophagitis, and Zollinger-Ellison Syndrome.
Dosage (summary)
150 mg twice daily or 300 mg at bedtime; adjust for renal impairment.
Onset of Action / Duration
Onset: 1-3 hours, Duration: 6-12 hours
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety not established in pregnancy or lactation.
Key Drug Interactions
- Anticoagulants (e.g., warfarin)
- Procainamide
- Sucralfate
Contraindications
- Hypersensitivity to ranitidine
Common side effects
- Headache
- Dizziness
- Nausea
- Constipation
Counselling Points
- Take before meals or at bedtime.
- Avoid alcohol.
- Monitor for signs of allergic reactions.
Serious warnings
- Risk of masking gastric carcinoma
- Increased risk of pneumonia in certain populations
Important Disclaimer
The Zantac 150mg & 300mg Tablet professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
